Ciena's Q3 Blowout: Real Growth, a Fair Price, and an Entry Signal That Hasn't Turned

On September 3, Ciena reported a quarter that reads like the bull case printed out: revenue up 37% year over year, adjusted earnings per share up 215%, and full-year guidance raised on the strength of AI-driven optical-networking demand. The stock rose on the news. Someone still felt compelled to call the whole thing a "textbook buying opportunity" and an upgrade. The reason that phrase needs scrutiny: even after the report, the stock sits roughly a third below its July high. When a company posts numbers this good and the market hasn't pushed it back to its peak, something in the factor stack is not cooperating. I want to test which factor that is, because that difference is where the real decision lives.

Start with the part that is genuinely strong, because it is easy to lose sight of it behind the price action. Fiscal Q3 2026 revenue came in at $1.67 billion, up 37% from $1.22 billion a year earlier, on demand the company ties to AI buildouts. GAAP diluted EPS was $1.83; adjusted EPS was $2.11, up 215% from $0.67. Adjusted operating margin expanded to 22.5% from 10.7% — an 11.8-percentage-point jump in one year, which is operating leverage, not accounting games. Management then told investors fiscal fourth-quarter revenue would be about $1.75 billion and lifted the full-year figure to roughly $6.42 billion, a 35% increase from fiscal 2025. On the growth and revisions factors, this is a top-quartile report card: accelerating revenue, compounding margins, and estimates being raised, not trimmed. AInvest's aggregate signal labels the stock a Buy, which I'll take only as a cross-check, because the underlying operating numbers already make the case.

The valuation factor is where the "textbook buying opportunity" framing gets uncomfortable. A buying opportunity usually implies the price reset to a discount. It did not. Ciena trades at about 8.3 times trailing sales, roughly 65 times trailing EBITDA, and over 16 times book — rich any way you slice it. The crucial comparison, though, is against the right cohort. Its AI-optical peer Coherent trades at essentially the same multiple: about 8.4 times sales and 67 times EBITDA. So Ciena's multiple is not an anomaly relative to its sector; the pullback took it from overpriced relative to peers down to fairly priced relative to them. That is a different claim than "cheap." The three-month slide of roughly a third, from the low-$400s into the low-$300s, reset a hot AI-growth multiple to a full one. It did not manufacture a value stock.

That leaves momentum as the broken factor, and it deserves to be identified plainly as the source of the gap. The stock is below both its 50-day moving average (about $394) and its 200-day (about $380), with a 14-day RSI near 44 — mid-range, neither oversold nor confirmed recovery — and a negative MACD. Over the past 20 trading days it is still down about 20% even after this week's bounce. Today's gain of roughly 5%, and about 11% over five days, is a fresh reaction to the report, not yet a validated turn in trend. In my framework momentum and revisions are timing tools, not the thesis; but when growth says buy and momentum says not yet, the honest reading is that the entry, not the business, is what remains unconfirmed.

The risk the multiples will not show you sits in the revenue composition. Two customers each accounted for more than 10% of Ciena's fiscal Q3 revenue, together 41.7% of the total. That concentration is the counterweight to the margin story: the operating leverage that looks so attractive is levered to a small number of very large AI-network buyers, and a pause at either one would move the whole report card. The balance sheet is otherwise fine — about $2.4 billion in cash, roughly $600 million of net debt, a current ratio near 3.8 — so this is not a solvency question. It is a durability question dressed as a concentration number.

So where does the factor stack actually land? Growth A, on 37% revenue and 215% EPS growth. Revisions A, on raised guidance. Profitability A, on a 22.5% adjusted operating margin and 22% return on equity. Valuation: a weak grade on absolute cheapness but a fair grade against the AI-optical comp it actually competes with — not the discount the headline promises. Momentum: the one factor that has broken down, and the one that has not confirmed an entry. For anyone who already owns a stock up roughly 166% over the past year, culling it now because it gave back a third would be the mechanical mistake my process warns against — a proven leader delivering top-quartile growth is not a sell candidate just because the trend cooled. For new money, the disciplined read is different: this is a quality-growth sleeve add on weakness, sized patiently and waiting for the moving averages to turn, not a sprint into a stock whose price reset to fair while its trend is still working against it. The Q3 was a genuine blowout. Calling it a textbook buying opportunity, without noting that the valuation is fair rather than cheap and momentum has yet to confirm, is only half the textbook.